BHVN
Biohaven Pharmaceutical Holding Co Ltd
Mentions (24Hr)
-100.00% Today
Reddit Posts
Anyone know what happened to BHVN last month? Looks like a buy cheap moment depending on why they lost $140 a share in one month…
Pfizer to pay $11.6 billion for Biohaven to tap migraine market
Mentions
BHVN update at JPM HC looks very promising for a long term play. Been a series of misses for them recently.
Biohaven (BHVN) is up 22% today
Can confirm this as well. I have been closing csps at 60 to 80 percent profit within days across tickers. I have been selling them at about 30 to 40 dte but avoiding tail risk is part of my trading plan. I traded T, ET, VZ, PYPL, HOOD, UVXY, BHVN, SOFI, NVO for those wanting tickers.
VLVY = Against big names and strong competition, their revenue is dropping fast by quarter . Thanks for this I’ll buy puts against them . Serv=cash flow negative insanely, concept is cool but they Are worth 0$ a share, they couldn’t pay me to buy their shares . It cost the investors money currently for their little robots . BHVN = literally makes no money, haven’t sold a thing , why in the fk would you want this? It’s worth $0 “Mr wonderful tone” They make no money! Gloo= just started making revenue and loosing money hand over fist, they’ll dilute shareholders for more funds . Before I continue , fk dude learn the fundamentals behind companies , they companies are all negative with no future , straight hopeium. Beta = loosing money even with a few small aerospace contracts, they need to fund or dilute to live . UAL= actually profitable and increasing , however, near all time highs , has more room to drop on bad news then succeed on good news , lots of competitors . AA= now that interesting , just hit some good profitability metrics but chilling near all time highs , that could go either way especially with mining. CCJ= Gainging revenue and ground , looks good but all time highs again. Googl: Looks good but all time high agains , Hood = again good but all time highs . I I wouldn’t buy in at these P/E on any of these stocks even the few with good fundamentals Lastly: RDDT: I mean , sure they just gained profitability and the business model is mainly ads so that’s okay but I mean would you really buy Reddit at the price of Nvidia or AMD? Even Comcast on its downhill slope is $26.50 a share and blows Reddit out the water on earnings and revenue . I wouldn’t pay $100+ for a share of a company that makes so little income as a company compared to others . Nothing against Reddit , just overpriced.
What do you think of BHVN's degraders? Are they clearly worth the capex/risk needed to bring them to market?
Shkreli’s BHVN position is getting milked in PM today
Need IREN and RKLB to both break and or stay above $60. BHVN would be nice to see climb again too. Thanks for your attention to this matter
BHVN no! Not like this, my p00ts!
Biohaven $BHVN vol at 304%. FDA approval imminent. Fantastic opportunity to harvest premium!
Adding to $BHVN with its 314% vol. Just put $36k in premiums in my account selling puts on $BHVN today. From its 2025 bottom of $12.83 in late July, it’s climbed 34% to $17.23. What’s driving this? Excitement for troriluzole, their drug targeting spinocerebellar ataxia, a rare disease with no approved treatments. The FDA granted priority review in February 2025, and when they skipped the advisory committee meeting in August, shares jumped 6% in a single day. Q2 earnings also highlighted pipeline progress, despite a faster cash burn. Analysts estimate a 70-80% chance of FDA approval for troriluzole in Q4, supported by phase 3 data showing 50-70% slower disease progression. Approval could make Biohaven a first-mover with over $1 billion in potential sales, a game-changer for this biotech. It’s a high-stakes moment. For traders, BHVN’s options are compelling, with implied volatility at 314% compared to a historical 68%. This suggests potential 30% + price swings around the PDUFA date around Nov 10. Strategies like straddles or iron condors could capitalize on this volatility without overexposure. Given the stock’s 30-day standard deviation of $1.17, prudent position sizing is essential in this unpredictable biotech space. I’m taking the easy route selling $10 Nov strike puts and collecting juicy premium believing the stock won’t drop below its $12.79 low for the year by Nov 21 and I won’t be assigned. In short, BHVN offers substantial upside if troriluzole succeeds, potentially pushing shares toward $48 or higher. Options provide a smarter play than shares for navigating this volatility.
Check out the IV on BHVN... selling 11/21 csp at 10 or 12.5 looks like easy money. 52 week low is $12.79 and it doesn't look like it's going down.
BHVN PATH CCCX I can’t handle it anymore. My portfolio cannot contain all this
I have read some things stating that approval possibility could be as high as 70-85%. Obviously no knowing until the decision comes out. If there is news only insiders know, then we wouldn't likely have access to that. That is where looking for anomaly purchases comes I'm. The large calls premiums is conviction in my opinion. $2.1m bet on BHVN is significant for this ticker.
I’ll check it out! Bought some BHVN calls this morning.
It’s so good to be profitable and stop caring, did it last week with intc and this week PSKY, next week BHVN
I am still holding BHVN, which he said was a good buy at $20. I bought it at $17 and watched to go to $13. The nuclear company doesn't surprise me...
Anyone follow the company (stock) Biohaven (BHVN)?
BHVN gonna make me some bank 
Technical chart set ups: GMAB might have bottomed, BHVN (Alzheimer’s news recently) is consolidating nicely above 50. Looking for upside continuation
I bought BHVN shares yesterday and already up 10%, seems like a legit company thats doing great things
$BHVN Insiders buying like crazy Sold 12% short Insiders own +20% Many trials in phase 2 and phase 3 Options seem illiquid I have shares entered today at 34.22 avg is 34.58
BHVN down about 30% at one point before open now up about 30% off that low. Biotech is fun.
yep, I held all of my positions ($VRT, $SPY, $CMPS, and $BHVN) and I averaged down to about double my positions. I’m a doomer about the state of the world, but the U.S. economy isn’t crashing until the nukes start dropping, so i felt safe enough buying through the dip.
Primarily made my gains from trading $BHVN, $VRT, $MOD, and then safer bets like $SPY and $MSFT. $BHVN hasn’t made me money in a couple of months, but VRT is continuing to rake in cash and I’m expecting it to continue trending that way
I’ve been watching $SKYE and a few other small and mid cap obesity drug stocks. But I want to find a company whos stock hasn’t had a huge run up yet. Anyone watching anything interesting ? There’s lots of problems with GLP-1 technology and a small guy will do it. $BHVN $SRRK $KROS
The small cap obesity stocks are insane like $SAVA $SRRK $BHVN $KROS
What are your thoughts on BHVN?
the problem w/ Semaglutides is they remove muscle mass as well. [BHVN](https://www.morningstar.com/stocks/obesity-drug-stocks-where-invest-now) & others working on a drug that would increase muscle mass & target fat receptors Whoever hits that holy grail will moon
Making a drug isn't easy and there's considerable regulation on top of it, not sure why people think there is little moat to this sort of thing. So many people on here last year were arguing to buy Pfizer because "They're cheap and they have an obesity drug, too!" then their trial was a miss and then not long after that they lowered FY24 guidance. Amgen had data on their drug the other day and it was a bit mixed. There are some promising small companies with offerings (VKTX), but they can't arguably compete alone and it would not surprise me if someone bought one or more of the smaller players. Biohaven (BHVN) is also working on a drug that helps the quality of weight loss in regards to lean mass (https://www.biopharmadive.com/news/glp-1-biohaven-weight-loss-lean-muscle-ozempic/700290/), but LLY bought Versanis for that reason, as well. In any case, NVO/LLY have a massive lead - as someone else said they already had a "strong presence in metabolic medicine" to begin with. There will absolutely be competition, but I think LLY/NVO remain the dominant players for quite a few years to come. JP Morgan's report on GLP-1: "The GLP-1 landscape is currently dominated by two major players: U.S.-based Eli Lilly and Denmark-based Novo Nordisk. “We expect the obesity market to largely be a duopoly between both companies, with modest share attributed to later entrants,” Schott said (https://www.jpmorgan.com/insights/global-research/current-events/obesity-drugs)
Tracking some of Cramer's narrative as a follow up to yesterday's milestone. He certainly nailed it with the Sell Oracle call, which did fall 15% in two days. He also nailed last week's warning that ADBE would fall on earnings regardless of how good or bad they'd be. His big call yesterday that smaller and spec names should be sold is looking less pretty. Today's rally lifted those kind of names a bit more. In one particular case, UPST is up 25% on the day. I suppose in practical reality that could work out if someone took saw his sell call this morning and executed their sell at end of day, capturing the huge move. But if someone sold at the open... oof. His big narratives for today were: * that despite making some proper steps and having some potential in BHVN and SeaGen, Pfizer just isn't executing, now down from $29 in 2013 to $26 today. * that you're better off with LLY and how their research efforts are paying off * his other big narrative is that the interest rate sensitive names are ready to roar with the implied rate cuts coming. That we could see some rotation from Magnificent 7 into these and some tech laggards.
has anyone looked into BHVN at all? The guy that called Cramer got me intrigued 🤔
When I make long term investments i look at what management is doing. Because if management is buying that must mean they really believe in a turn around soon. Openinsider.com is a great place to check inside buying/selling. PYPL. Looks like management was making large sells at the end of last year. Yet to see any large buys. This would cross PYPL off my list for long term investment SHOP I can not find SEC filings in the last 6 months. Would need to dig deeper to make a decision. UPST Also large sales at the end of last year up to June. No buying as of now. I would cross this off the list as well as a long term investment. Shop would require more FA to determine a decision at this moment and is the only Equity I could not give an answer on. Lastly I would not focus on % drops and P/E as determining factors for investments. Because it sounds like you are taking a value investing approach. I can elaborate more on my system if you would like and how I get my value investments. One I have found which is a great choice with its own risk is BHVN. Bio tec that has just been Bought by Pfizer. Has two drugs in phase 3 of testing giving it a 50-60 percent or more of getting one drug approved by the fda. Insider buying totaling more than 50 million by management. Sounds to me like management believes they have hit a home run.
My BHVN still green
From seeking alpha Although Pfizer completed its acquisition of Biohaven Pharmaceuticals on Monday, the company lives on as a separately traded company, Biohaven Ltd. (NYSE:BHVN), due to a spinoff before the acquisition closed
can anyone tell me why NOT to go all in on **Biohaven (BHVN)**, with $150 and $350 1 and 5 yr forecasts ($10 stock rn). Already bought 75 shares. HODL? I LIKE THIS STOCK! Thoughts? Or just murder me in comments, idk
It was an acquisition and then spin-off. All the shareholders of BHVN received $148.50 cash and 1 share of BHVN SpinCo for each share BHVN they held prior. Pfizer filed a Form 10 for the listing of BHVN. Here’s the press release: https://www.pfizer.com/news/press-release/press-release-detail/pfizer-completes-acquisition-biohaven-pharmaceuticals Did you buy the puts pre or post-spin? If you bought post-spin ignore what I’ve said. Sometimes it takes times for things to show up properly in brokerages. If they were bought pre-spin they’re worthless because each share of BHVN pre-spin is worth $148.50 of cash + $11 SpinCo and unless you somehow get negative equity out of the SpinCo it’ll always be above the $75 strike.
The company was not acquired, hence why BHVN is still an active listing on the NYSE. Pfizer bought out part of the R&D division that did migraine medicine. BHVN is still a company, and therefore the contracts are still valid they just have an ADJ rate on them.
CSCW BHVN RMED FWBI SPRO FNGR FCRD KITT PEAR Thank me Friday pre market. Get it while it’s low. Getting juiced. Join the squeeze.
BHVN was at least going to make me a fortune before they split. Company makes $0 and has negative revenue. It’s a huge turd that was trading for $140, even after they sold the best part of their business to Pfizer. I think they go bankrupt, and if that happens I would have been a millionaire off of $100 in puts. Will post Gain Porn from my yacht if it happens
BHVN was at least going to make me a fortune before they split. Company makes $0 and has negative revenue. It’s a huge turd that was trading for $140, even after they sold the best part of their business to Pfizer. I think they go bankrupt, and if that happens I would have been a millionaire off of $100 in puts. Will post Gain Porn from my yacht if it happens
Already have my puts for the next 6 months to a year in. Jan 2024 Rivian - $12.50 Jan 2023 NIO - $10.00 March 2023 SPY - $300.00 December 2023 BHVN - $75 (ADJ)
If you ever feel bad about leaving money on the table, take a look at BHVN. Down -94% today.
What happens to biohaven BHVN??
>Pfizer Completes Acquisition Of Biohaven Pharmaceuticals $PFE $BHVN ^\*Walter ^Bloomberg ^[@DeItaone](http://twitter.com/DeItaone) ^at ^2022-10-03 ^13:01:21 ^EDT-0400
Ignored biotech for this list for the sake of not having to do the research on each one. Biotech with the greatest cash burn with market cap over 10B: BGNE, ARGX, BHVN, BIO, and SGEN
news: \- $COIN / $RBLX / $PTON 📉 \- US gives $40B to Ukraine \- $UST still down \- Bostic: 2 50BPS \- $AAPL EV patent, axes iPod touch \- $BHVN x $PFE \- $EA loses FIFA \- $FB x $MATIC \- Schumer: banning Congress stock trading on schedule
Why did BHVN move so much today? 5.9.22- closed at like 83 5.10.22- closed at 140.00 Why did it jump so much on no news?
BHVN is doing just that god i need Biff's almanac
Now where to go next with my BHVN profits? I really like SBUX at these levels and I’ve had my eye on it for a while. Like of negativity priced in the stock that will work itself out. Or I could just go super conservative and put it in BRK.B
Best thing to happen to my portfolio in a very long time. Phizer just bought put BHVN! Up 70% after the buyout and 50% overall on the position. Time to sell it all and move on to the next one!
Why the hell is BHVN dropping over 7% on no news?
Well I was having a good day until three companies that I own reported. MTZ, BHVN, and STEM are all down coming off of earnings. All for good reason, just a little frustrating. Even though STEM is unprofitable, their tremendous growth YOY and backlog makes me incredibly bullish on the company.
Biotech is one of the most volatile and rewarding sectors. Trading them are harder, but can make you tons of $. Got into BHVN at $28 and it’s paid nicely. Didn’t trade them though, I just held them,
From top 25 holdings - M at +15%, SAIA at +5%, BHVN at +3.5%, BJ at +2.5% The ones that are double-digit red are basically memes.
Let’s share our top 5 best performing stocks of 2021. Here are mine: BHVN - 56.91% AMD - 53.66% AAPL - 29.72% NOK - 23.15% GOOGL - 18.42%
They keep saying everyone is selling risk and buying safe, profitable companies yet today I’m down in ABBV, AAPL, GOOGL, and WMT. those are pretty safe. Only one of my unprofitable companies that is down is BHVN
My stocks that are up rn: ABBV (ok), BHVN (this one is a monster), SOFI (?), and MTZ.
Whats the elevator pitch on $BHVN? I’ve been interested but hesitant to go in.
>Biohaven and Pfizer Enter Strategic Collaboration for the Commercialization of Rimegepant Outside the United States $BHVN $PFE ^\*Walter ^Bloomberg ^[@DeItaone](http://twitter.com/DeItaone) ^at ^2021-11-09 ^07:48:12 ^EST-0500
alright anyone on these earnings PM tomorrow: PLTR, WKHS, UWMC, SYY, BHVN, HUYA
HON is a crappy stock? BHVN? ABBV? MTZ? CLF? None of those are crappy companies.
For a real time example. Look at BHVN 7/16 135 calls. The bid is at 0.00 and the ask is at 1.00. The mid would show at .50 but realistically there are no buyers even willing to pay 0.00 for the option contract.
Sold off some of my gains from BHVN and bought the dips on SOFI, GE, MTZ, BABA, and a little PSFE.
BHVN is taking a leap premarket. I’ve honestly gotten so lucky on picking this stock.
Let’s play a game of am I diversified. My top five holdings: BHVN, CLF, NIO, HON, and AMD.
Anyone else holding BHVN? I’m way up on this stock. Like it’s run up like crazy. Don’t think I’m going to sell any but I’m definitely not buying anymore right now.
BHVN has been killing it last 3 weeks
I’ve made more than triple my money with BHVN. If anyone is looking for a backup. Bhvn
I’ll give you a few: HON, NEE, and BHVN
EBS, BHVN, NBIX oh and my personal fave ... BMRN. You could have made a fortune shorting any of them. Oh yeah and even if you like vaccine stocks, you must love the 80% draw down in VIR and NVAX is only down 140 from 7 weeks ago
Stocks that are green for me today: AAPL, JPM, WMT, BHVN, AMD, SONY, EXC AND NOK. Pretty random besides the tech names.